5 September 2026
Symptom-free adults begin screening for phase III trontinemab prevention trial
About 1,600 people aged 55 to 80 worldwide are slated for screening.
The full briefing is in the app.
5 September 2026
About 1,600 people aged 55 to 80 worldwide are slated for screening.
The full briefing is in the app.